Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.
Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
This fourth edition of Depression in New Mothers, Volume 2: Screening, Assessment, and Treatment Alternatives provides a comprehensive and evidence-based approach to understanding the assessment for treatment and treatment of postpartum depression.
This fourth edition of Depression in New Mothers, Volume 2: Screening, Assessment, and Treatment Alternatives provides a comprehensive and evidence-based approach to understanding the assessment for treatment and treatment of postpartum depression.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Die Herstellerinformationen sind derzeit nicht verfügbar.
Autorenporträt
Kathleen A. Kendall-Tackett is a health psychologist and international board-certified lactation consultant (IBCLC). Dr. Kendall-Tackett is Editor-in-Chief of the journal Psychological Trauma. She is a fellow of the American Psychological Association in Health and Trauma Psychology, the past president of the APA Division of Trauma Psychology, and a member of Postpartum Support International's President's Advisory Council. Dr. Kendall-Tackett has published over 500 articles on women's health, breastfeeding, depression, trauma, and health psychology. This is her 42nd book.
Inhaltsangabe
Section I: Screening for Depression and Co-Morbid Conditions. 1.Screening: Rationale and Barriers. 2.Selcting Screening Scales: General Considerations. 3.The Edinburgh Postnatal Depression Scale (EPDS). 4.The Patient Health Questionnaires. 5. Other Screening Tools. 6.Assessing for Symptom Severity, Maternal Suicide Risk, And Possible Infant Harm. Section II: Complementary and Integrative Treatments. 7. An Integrative Approach to Treatment. 8. Nutraceuticals I: Long-Chain Omega-3 Fatty Acids. 9. Nutraceuticals II: Vitamin D, Vitamin B-12, Curcumin, And St. John's Wort. 10. Exercise. 11. Bright Light Therapy. 12.Emerging Cam Treatments. Section III: Community Interventions. 13. Social Support: The Foundation to Community Support. 14.Peer and Healthcare Provider Support. 15.Home Visiting, Education, And Infant Massage. Section IV: Psychotherapy. 16.Cognitive-Behavioral Therapy. 17.Interpersonal Psychotherapy. 18. Trauma-Informed Care and Trauma Treatment. Section V: Medications. 19. Overview Of Antidepressants. 20. Antidepressants for Pregnant or Breastfeeding Women. 21. Atypical Antidepressants: Ketamine and Brexanolone. 22. Putting It All Together.
Section I: Screening for Depression and Co-Morbid Conditions. 1.Screening: Rationale and Barriers. 2.Selcting Screening Scales: General Considerations. 3.The Edinburgh Postnatal Depression Scale (EPDS). 4.The Patient Health Questionnaires. 5. Other Screening Tools. 6.Assessing for Symptom Severity, Maternal Suicide Risk, And Possible Infant Harm. Section II: Complementary and Integrative Treatments. 7. An Integrative Approach to Treatment. 8. Nutraceuticals I: Long-Chain Omega-3 Fatty Acids. 9. Nutraceuticals II: Vitamin D, Vitamin B-12, Curcumin, And St. John's Wort. 10. Exercise. 11. Bright Light Therapy. 12.Emerging Cam Treatments. Section III: Community Interventions. 13. Social Support: The Foundation to Community Support. 14.Peer and Healthcare Provider Support. 15.Home Visiting, Education, And Infant Massage. Section IV: Psychotherapy. 16.Cognitive-Behavioral Therapy. 17.Interpersonal Psychotherapy. 18. Trauma-Informed Care and Trauma Treatment. Section V: Medications. 19. Overview Of Antidepressants. 20. Antidepressants for Pregnant or Breastfeeding Women. 21. Atypical Antidepressants: Ketamine and Brexanolone. 22. Putting It All Together.
Section I: Screening for Depression and Co-Morbid Conditions. 1.Screening: Rationale and Barriers. 2.Selcting Screening Scales: General Considerations. 3.The Edinburgh Postnatal Depression Scale (EPDS). 4.The Patient Health Questionnaires. 5. Other Screening Tools. 6.Assessing for Symptom Severity, Maternal Suicide Risk, And Possible Infant Harm. Section II: Complementary and Integrative Treatments. 7. An Integrative Approach to Treatment. 8. Nutraceuticals I: Long-Chain Omega-3 Fatty Acids. 9. Nutraceuticals II: Vitamin D, Vitamin B-12, Curcumin, And St. John's Wort. 10. Exercise. 11. Bright Light Therapy. 12.Emerging Cam Treatments. Section III: Community Interventions. 13. Social Support: The Foundation to Community Support. 14.Peer and Healthcare Provider Support. 15.Home Visiting, Education, And Infant Massage. Section IV: Psychotherapy. 16.Cognitive-Behavioral Therapy. 17.Interpersonal Psychotherapy. 18. Trauma-Informed Care and Trauma Treatment. Section V: Medications. 19. Overview Of Antidepressants. 20. Antidepressants for Pregnant or Breastfeeding Women. 21. Atypical Antidepressants: Ketamine and Brexanolone. 22. Putting It All Together.
Section I: Screening for Depression and Co-Morbid Conditions. 1.Screening: Rationale and Barriers. 2.Selcting Screening Scales: General Considerations. 3.The Edinburgh Postnatal Depression Scale (EPDS). 4.The Patient Health Questionnaires. 5. Other Screening Tools. 6.Assessing for Symptom Severity, Maternal Suicide Risk, And Possible Infant Harm. Section II: Complementary and Integrative Treatments. 7. An Integrative Approach to Treatment. 8. Nutraceuticals I: Long-Chain Omega-3 Fatty Acids. 9. Nutraceuticals II: Vitamin D, Vitamin B-12, Curcumin, And St. John's Wort. 10. Exercise. 11. Bright Light Therapy. 12.Emerging Cam Treatments. Section III: Community Interventions. 13. Social Support: The Foundation to Community Support. 14.Peer and Healthcare Provider Support. 15.Home Visiting, Education, And Infant Massage. Section IV: Psychotherapy. 16.Cognitive-Behavioral Therapy. 17.Interpersonal Psychotherapy. 18. Trauma-Informed Care and Trauma Treatment. Section V: Medications. 19. Overview Of Antidepressants. 20. Antidepressants for Pregnant or Breastfeeding Women. 21. Atypical Antidepressants: Ketamine and Brexanolone. 22. Putting It All Together.
Rezensionen
In Depression in New Mothers, Vol II, Kathleen Kendall-Tackett provides a clear clinical context for the necessity of effective screening and assessment as the critical link to promoting successful treatment outcomes. She identifies the wide range of screening tools, their benefits and drawbacks, and current evidence-based treatments beyond just a pharmacological approach. This text is an invaluable roadmap for best practices in decision-making for the field of maternal mental health.
Diana L. Barnes, Psy.D PMH-C
This book comprehensively overviews screening and treatment options for a woman experiencing perinatal mental health conditions. It covers evidenced-based complementary, alternative, and integrative therapies well. An amazing overview of psychotherapy as a treatment and a review of medication options. A highly recommended informative book for practitioners in the field of perinatal mental health.
Birdie Gunyon Meyer, RN, MA, PMH-C, Certification and Training Director, Postpartum Support International
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der buecher.de internetstores GmbH
Geschäftsführung: Monica Sawhney | Roland Kölbl | Günter Hilger
Sitz der Gesellschaft: Batheyer Straße 115 - 117, 58099 Hagen
Postanschrift: Bürgermeister-Wegele-Str. 12, 86167 Augsburg
Amtsgericht Hagen HRB 13257
Steuernummer: 321/5800/1497
USt-IdNr: DE450055826